EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

High-Dose Epidermal Radionuclide Therapy with 188Re (Rhenium) Resin in a Patient with Multiple Actinic Keratoses

Siroos Mirzaei iD, Rainer Kunstfeld

World Journal of Nuclear Medicine · 2024-12 · 23 (04) · 285-287

DOI: 10.1055/s-0044-1788075 ↗

Kurz gefasst

Fallbericht in der Zeitschrift World Journal of Nuclear Medicine, online erschienen am 04.07.2024. Verfasst von Siroos Mirzaei und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine with PET-Centre, Clinic Ottakring, Vienna, Austria. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

High-dose epidermal radionuclide therapy using a nonsealed 188Re (Rhenium) resin is an alternative treatment option for nonmelanoma skin cancer. In this case study, we present the possible use of this therapy in a patient with multiple actinic keratosis (AK), which is a precancer of the skin.

Methods

A 55-year-old male was presented in our department with multiple AK, located on the cheek, temporal, and frontal area, with 1, 1, 2.1, and 2.5 cm2 surface. Applied activity was 80, 80, 167, and 168 MBq 188Re with a target absorbed dose for each lesion 35 Gy at 1 mm. The treatment was well tolerated.

Results

At 17 months’ follow-up, all treated area showed complete remission. There were no side effects, except mild focal hypopigmentation.

Conclusion

This case demonstrates the high potential of epidermal radionuclide therapy with a nonsealed 188Re as a noninvasive, effective, and well-tolerated therapy option for patients with multiple AK, when surgery is difficult to perform or not recommended of other reasons.

Schlagwörter

Stichwörter der Autor:innen

Rhenium-188actinic keratosisepidermal therapyradionuclide therapyskin cancer

Autor:innen und Institutionen

  • Department of Nuclear Medicine with PET-Centre, Clinic Ottakring, Vienna, Austria.
  • University Department for Dermatology, Medical University Vienna, Vienna, Austria.

ORCID-Profile: Siroos Mirzaei

Zitieren

APA

Mirzaei, S., & Kunstfeld, R. (2024). High-Dose Epidermal Radionuclide Therapy with 188Re (Rhenium) Resin in a Patient with Multiple Actinic Keratoses. World Journal of Nuclear Medicine, 23(04), 285-287. https://doi.org/10.1055/s-0044-1788075

Vancouver

Mirzaei S, Kunstfeld R. High-Dose Epidermal Radionuclide Therapy with 188Re (Rhenium) Resin in a Patient with Multiple Actinic Keratoses. World Journal of Nuclear Medicine. 2024;23(04):285-287. doi:10.1055/s-0044-1788075

BibTeX
@article{Mirzaei2024,
  author = {Mirzaei, Siroos and Kunstfeld, Rainer},
  title = {High-Dose Epidermal Radionuclide Therapy with 188Re (Rhenium) Resin in a Patient with Multiple Actinic Keratoses},
  journal = {World Journal of Nuclear Medicine},
  year = {2024},
  volume = {23},
  number = {04},
  pages = {285--287},
  doi = {10.1055/s-0044-1788075}
}
Kostenlos starten →